The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis-Reference-Cited by-同舟云学术

The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis

Published:2021-08-30 Issue: Volume: Page:1-21
ISSN:1743-7199
Container-title:Health Psychology Review
language:en
Short-container-title:Health Psychology Review

Author:

Gasteiger Chiara¹^ORCID,den Broeder Alfons A.²^ORCID,Stewart Sarah³^ORCID,Gasteiger Norina⁴^ORCID,Scholz Urte⁵⁶^ORCID,Dalbeth Nicola⁷⁸^ORCID,Petrie Keith J.¹^ORCID

Affiliation:

1. Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

2. Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands

3. Bone & Joint Research Group, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

4. School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom

5. Department of Psychology- Applied Social and Health Psychology, University of Zurich, Zurich, Switzerland

6. University Research Priority Program ‘Dynamics of Healthy Aging’, University of Zurich, Zurich, Switzerland

7. Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand

8. Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17437199.2021.1970610

Reference101 articles.

1. Current perspectives on biosimilars

2. E014 Patient experience of switching to biosimilar Benepali

3. Health care consumers’ experiences of information communication technology—A summary of literature

4. Real Life Switching from Infliximab Innovator to Biosimilar in Rheumatic Diseases: A 6-Month Single-Centre Prospective Observational Study

5. Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Nocebo Effect;Annual Review of Pharmacology and Toxicology;2024-01-23

2. Rheumatology Patients’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar;ACR Open Rheumatology;2023-11-23

3. Health Care Providers’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar;ACR Open Rheumatology;2023-10

4. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice;Osteoporosis International;2023-01-04

5. Using family-centered communication to optimize patient-provider-companion encounters about changing to biosimilars: A randomized controlled trial;Patient Education and Counseling;2023-01